Ra Medical Systems Regains Compliance with NYSE American Continued Listing Standards
14 Dezembro 2022 - 6:33PM
Business Wire
Ra Medical Systems, Inc. (NYSE American: RMED) (“Ra Medical” or
the “Company”) announces that it has received notification from the
NYSE American LLC (“NYSE American”) that the Company has regained
compliance with the NYSE American’s continued listing standard.
Specifically, the Company has resolved the continued listing
deficiency with respect to its low selling price as described in
Section 1003(f)(v) of the NYSE American Company Guide.
In the notification, the NYSE American informed the Company that
as of December 9, 2022, the below compliance (“.BS) indicator will
no longer be disseminated and the Company has been removed from the
NYSE American noncompliant issuers on the NYSE American’s
website.
About Ra Medical Systems
Ra Medical Systems, Inc. is a medical device company that owns
intellectual property related to an advanced excimer laser-based
platform for use in the treatment of vascular immune-mediated
inflammatory diseases. Its excimer laser and single-use catheter
system, together referred to as the DABRA Excimer Laser System, is
used as a tool in the treatment of peripheral artery disease.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20221214006025/en/
LHA Investor Relations Jody Cain 310-691-7100 jcain@lhai.com
Ra Medical Systems (NYSE:RMED)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Ra Medical Systems (NYSE:RMED)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024
Notícias em tempo-real sobre Ra Medical Systems Inc da New York Stock Exchange bolsa de valores: 0 artigos recentes
Mais Notícias de Ra Medical Systems Inc